| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |